These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 17933978)

  • 1. Evidence of intrathyroidal B-lymphocyte depletion after rituximab therapy in a patient with Graves' disease.
    El Fassi D; Clemmensen O; Nielsen CH; Silkiss RZ; Hegedüs L
    J Clin Endocrinol Metab; 2007 Oct; 92(10):3762-3. PubMed ID: 17933978
    [No Abstract]   [Full Text] [Related]  

  • 2. The rationale for B lymphocyte depletion in Graves' disease. Monoclonal anti-CD20 antibody therapy as a novel treatment option.
    El Fassi D; Nielsen CH; Hasselbalch HC; Hegedüs L
    Eur J Endocrinol; 2006 May; 154(5):623-32. PubMed ID: 16645007
    [TBL] [Abstract][Full Text] [Related]  

  • 3. B-cell depletion with rituximab-a targeted therapy for Graves' disease and autoimmune thyroiditis.
    Hasselbalch HC
    Immunol Lett; 2003 Jul; 88(1):85-6. PubMed ID: 12853167
    [No Abstract]   [Full Text] [Related]  

  • 4. Rituximab induces distinct intraorbital and intrathyroidal effects in one patient satisfactorily treated for Graves' ophthalmopathy.
    Bonara P; Vannucchi G; Campi I; Rossi S; Cantoni F; Frugoni C; Sbrozzi F; Guastella C; Avignone S; Beck-Peccoz P; Salvi M
    Clin Rev Allergy Immunol; 2008 Feb; 34(1):118-23. PubMed ID: 18270865
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methimazole has no dose-related effect on the intensity of the intrathyroidal autoimmune process in relapsing Graves' disease.
    Paschke R; Vogg M; Kristoferitsch R; Aktuna D; Wawschinek O; Eber O; Usadel KH
    J Clin Endocrinol Metab; 1995 Aug; 80(8):2470-4. PubMed ID: 7629244
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation of microsomal antibodies with the intensity of the intrathyroidal autoimmune process in Graves' disease.
    Paschke R; Vogg M; Swillens S; Usadel KH
    J Clin Endocrinol Metab; 1993 Oct; 77(4):939-43. PubMed ID: 8408468
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New immunomodulators in the treatment of Graves' ophthalmopathy.
    Salvi M; Vannucchi G; Campi I; Currò N; Beck-Peccoz P
    Ann Endocrinol (Paris); 2008 Apr; 69(2):153-6. PubMed ID: 18417090
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Novel treatment of Graves' disease using the B-lymphocyte depleting agent rituximab].
    Nielsen CH; El Fassi D; Hegedüs L
    Ugeskr Laeger; 2008 Jun; 170(24):2131-4. PubMed ID: 18565295
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence of orbital B and T cell depletion after rituximab therapy in Graves' ophthalmopathy.
    Nielsen JF; El Fassi D; Nielsen CH; Hegedüs L; Lauer SA; Silkiss RZ; Prause JU
    Acta Ophthalmol; 2009 Nov; 87(8):927-9. PubMed ID: 19785644
    [No Abstract]   [Full Text] [Related]  

  • 10. B-cell depletion with rituximab in the treatment of autoimmune diseases. Graves' ophthalmopathy the latest addition to an expanding family.
    Nielsen CH; El Fassi D; Hasselbalch HC; Bendtzen K; Hegedüs L
    Expert Opin Biol Ther; 2007 Jul; 7(7):1061-78. PubMed ID: 17665994
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The relationship between intrathyroidal dendritic cells and humoral immune disorder in Graves' disease].
    Zhang HJ; Li DM; Gao DL; Zhang L; Cao J; Zhao ZH; Zhang YH; Xu L
    Zhonghua Nei Ke Za Zhi; 2005 Feb; 44(2):122-4. PubMed ID: 15840225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ulcerative colitis following B lymphocyte depletion with rituximab in a patient with Graves' disease.
    El Fassi D; Nielsen CH; Kjeldsen J; Clemmensen O; Hegedüs L
    Gut; 2008 May; 57(5):714-5. PubMed ID: 18408106
    [No Abstract]   [Full Text] [Related]  

  • 13. Part 2: Synopsis of B-lymphocyte targeted therapy of ANCA-associated vasculitis.
    Golbin JM; Specks U
    Clin Exp Rheumatol; 2007; 25(1 Suppl 44):S74-6. PubMed ID: 17428376
    [No Abstract]   [Full Text] [Related]  

  • 14. Treatment-resistant severe, active Graves' ophthalmopathy successfully treated with B lymphocyte depletion.
    El Fassi D; Nielsen CH; Hasselbalch HC; Hegedüs L
    Thyroid; 2006 Jul; 16(7):709-10. PubMed ID: 16889501
    [No Abstract]   [Full Text] [Related]  

  • 15. B lymphocyte depletion with the monoclonal antibody rituximab in Graves' disease: a controlled pilot study.
    El Fassi D; Nielsen CH; Bonnema SJ; Hasselbalch HC; Hegedüs L
    J Clin Endocrinol Metab; 2007 May; 92(5):1769-72. PubMed ID: 17284622
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Abnormal B lymphocyte function in thyroid glands from patients with Graves' disease.
    Ueki Y; Eguchi K; Otsubo T; Kawabe Y; Shimomura C; Tezuka H; Nakao H; Kawakami A; Migita K; Ishikawa
    J Clin Endocrinol Metab; 1989 Nov; 69(5):939-45. PubMed ID: 2793996
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeted biological therapies for Graves' disease and thyroid-associated ophthalmopathy. Focus on B-cell depletion with Rituximab.
    Hegedüs L; Smith TJ; Douglas RS; Nielsen CH
    Clin Endocrinol (Oxf); 2011 Jan; 74(1):1-8. PubMed ID: 20455896
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum BAFF concentrations in patients with Graves' disease and orbitopathy before and after immunosuppressive therapy.
    Vannucchi G; Covelli D; Currò N; Dazzi D; Maffini A; Campi I; Bonara P; Guastella C; Pignataro L; Ratiglia R; Beck-Peccoz P; Salvi M
    J Clin Endocrinol Metab; 2012 May; 97(5):E755-9. PubMed ID: 22399512
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The influence of iodine on the intensity of the intrathyroidal autoimmune process in Graves' disease.
    Paschke R; Vogg M; Winter J; Wawschinek O; Eber O; Usadel KH
    Autoimmunity; 1994; 17(4):319-25. PubMed ID: 7948614
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thyroid-associated orbitopathy.
    Tarabishy AB; Lewis CD; Perry JD
    Ophthalmology; 2010 Sep; 117(9):1864; author reply 1864-5. PubMed ID: 20816259
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.